| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 338,278 | 345,177 | 336,835 | 339,755 | | Cost of Revenue | 73,172 | 70,035 | 65,019 | 65,424 | | | Gross Profit | 265,106 | 275,142 | 271,816 | 274,331 | | | Operating Expenses | | Research Development | 114,116 | 104,989 | 102,996 | 97,807 | | Selling General and Administrative | 121,739 | 105,708 | 111,211 | 104,566 | | Non Recurring | 1,200 | 400 |
-
| 600 | | Others | 3,129 | 2,956 | 2,941 | 3,786 | | | | Total Operating Expenses | 240,184 | 214,053 |
-
| 206,759 | | | | Operating Income or Loss | 24,922 | 61,089 | 54,668 | 67,572 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,891 | 5,384 | 10,445 | 2,099 | | Earnings Before Interest And Taxes | 31,813 | 66,473 | 65,113 | 69,671 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 31,813 | 66,473 | 65,113 | 69,671 | | Income Tax Expense | 12,285 | 19,037 | 16,825 | 17,242 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 19,528 | 47,436 | 48,288 | 52,429 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,528 | 47,436 | 48,288 | 52,429 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $19,528 | $47,436 | $48,288 | $52,429 |
|
0.51% Nasdaq 
Income Statement
